Attorneys

Philip E. Hansen, Ph.D.

Practice Areas

Industries

Philip E. Hansen, Ph.D., brings 16 years of experience as a research chemist in the pharmaceutical industry and 39 years as a patent agent to the prosecution of patent applications. Now semi-retired, he has spent his entire career in the field of organic medicinal chemistry.

His undergraduate thesis at Princeton was "Synthesis of 6,7-Disubstituted Pteridines." Phil's Ph.D. thesis at Cornell was titled "The Total Synthesis of Aureomycin and Tetracycline."

For 16 years, he was a senior research chemist at Sterling Drug (since absorbed into Sanofi Aventis), where he worked on bronchodilators and antibiotics (aminoglycosides and beta lactams), finishing up in peptide analgesics and antihypertensive agents. He was recruited into the patent department while at Sterling, where he was a patent agent.

Phil’s patent drafting, prosecution and counseling work is mostly confined to small molecule therapeutics, including related processes and formulations.

Phil's practice is worldwide. Representative clients include Sumitomo Pharmaceuticals America, Icahn School of Medicine at Mount Sinai, The Rockefeller University and Stanford University.

He is fluent in German with a working knowledge of French.

  • Cornell University, Ph.D., chemistry, 1970
  • Princeton University, A.B., chemistry, 1966
  • National Institutes of Health predoctoral fellow
  • United States Patent and Trademark Office
  • Overview

    Philip E. Hansen, Ph.D., brings 16 years of experience as a research chemist in the pharmaceutical industry and 39 years as a patent agent to the prosecution of patent applications. Now semi-retired, he has spent his entire career in the field of organic medicinal chemistry.

    His undergraduate thesis at Princeton was "Synthesis of 6,7-Disubstituted Pteridines." Phil's Ph.D. thesis at Cornell was titled "The Total Synthesis of Aureomycin and Tetracycline."

    For 16 years, he was a senior research chemist at Sterling Drug (since absorbed into Sanofi Aventis), where he worked on bronchodilators and antibiotics (aminoglycosides and beta lactams), finishing up in peptide analgesics and antihypertensive agents. He was recruited into the patent department while at Sterling, where he was a patent agent.

    Phil’s patent drafting, prosecution and counseling work is mostly confined to small molecule therapeutics, including related processes and formulations.

    Phil's practice is worldwide. Representative clients include Sumitomo Pharmaceuticals America, Icahn School of Medicine at Mount Sinai, The Rockefeller University and Stanford University.

    He is fluent in German with a working knowledge of French.

  • Publications
  • Education
    • Cornell University, Ph.D., chemistry, 1970
    • Princeton University, A.B., chemistry, 1966
  • Recognitions
    • National Institutes of Health predoctoral fellow
  • Memberships
  • Admissions
    • United States Patent and Trademark Office